Literature DB >> 25956511

Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury.

Jianjun Zhang1, Conghui Han2, Huijuan Dai1, Jianquan Hou3, Yang Dong2, Xiaolan Cui1, Longmei Xu4, Ming Zhang5, Qiang Xia5.   

Abstract

Natural killer T (NKT) cells are the major early-acting immune cell type and fundamental immune modulators in ischemia-reperfusion injury (IRI). Because lymphocytes are exposed to various oxygen tensions under pathophysiologic conditions, we hypothesize that hypoxia-inducible factors (HIFs) have roles in NKT cell activation, and thus determine the final outcome of renal IRI. In this study, we used Lck-Cre transgenic mice to specifically disrupt HIF-2α in T/NKT cells and found that HIF-2α knockout led to upregulated Fas ligand expression on peripheral NKT cells, but not on conventional T cells. HIF-2α knockout promoted infiltration of NKT cells into ischemic kidneys and exacerbated IRI, which could be mitigated by in vivo NK1.1(+) cell depletion or Fas ligand blockade. Compared with wild-type NKT cells, HIF-2α(-/-) NKT cells adoptively transferred to Rag1-knockout mice elicited more severe renal injury, and these mice were not protected by CGS21680, an adenosine A2A receptor agonist. Mechanistically, hypoxia-induced expression of adenosine A2A receptor in NKT cells and CGS21680-induced cAMP production in thymocytes were HIF-2α-dependent. Hydrogen peroxide-induced Fas ligand expression on thymic wild-type NKT cells was significantly attenuated by CGS21680 treatment, but this effect was lost in HIF-2α(-/-) NKT cells. Finally, CGS21680 and LPS, an inducer of HIF-2α in endothelium, synergistically reduced renal IRI substantially, but this effect was absent in Mx1-Cre-induced global HIF-2α-knockout mice. Taken together, our results reveal a hypoxia/HIF-2α/adenosine A2A receptor axis that restricts NKT cell activation when confronted with oxidative stress and thus protects against renal IRI.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  hypoxia; immunology; ischemia-reperfusion; ischemic renal failure

Mesh:

Substances:

Year:  2015        PMID: 25956511      PMCID: PMC4696581          DOI: 10.1681/ASN.2014121248

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  54 in total

1.  Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells.

Authors:  M Koshiba; H Kojima; S Huang; S Apasov; M V Sitkovsky
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

2.  Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.

Authors:  Kang He; Xiaosong Chen; Conghui Han; Longmei Xu; Jianjun Zhang; Ming Zhang; Qiang Xia
Journal:  Kidney Int       Date:  2013-09-11       Impact factor: 10.612

3.  Culturing at atmospheric oxygen levels impacts lymphocyte function.

Authors:  Kondala R Atkuri; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

4.  Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes.

Authors:  Dmitriy Lukashev; Boris Klebanov; Hidefumi Kojima; Alex Grinberg; Akiko Ohta; Ludmilla Berenfeld; Roland H Wenger; Akio Ohta; Michail Sitkovsky
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

5.  Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion.

Authors:  S Huang; S Apasov; M Koshiba; M Sitkovsky
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

6.  Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.

Authors:  Linda Holmquist-Mengelbier; Erik Fredlund; Tobias Löfstedt; Rosa Noguera; Samuel Navarro; Helén Nilsson; Alexander Pietras; Johan Vallon-Christersson; Ake Borg; Katarina Gradin; Lorenz Poellinger; Sven Påhlman
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

7.  HIF-dependent induction of adenosine A2B receptor in hypoxia.

Authors:  Tianqing Kong; Karen A Westerman; Marion Faigle; Holger K Eltzschig; Sean P Colgan
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

8.  H(2)O(2) induces upregulation of Fas and Fas ligand expression in NGF-differentiated PC12 cells: modulation by cAMP.

Authors:  F Facchinetti; S Furegato; S Terrazzino; A Leon
Journal:  J Neurosci Res       Date:  2002-07-15       Impact factor: 4.164

9.  Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria.

Authors:  Yuki Kinjo; Petr Illarionov; José Luis Vela; Bo Pei; Enrico Girardi; Xiangming Li; Yali Li; Masakazu Imamura; Yukihiro Kaneko; Akiko Okawara; Yoshitsugu Miyazaki; Anaximandro Gómez-Velasco; Paul Rogers; Samira Dahesh; Satoshi Uchiyama; Archana Khurana; Kazuyoshi Kawahara; Hasan Yesilkaya; Peter W Andrew; Chi-Huey Wong; Kazuyoshi Kawakami; Victor Nizet; Gurdyal S Besra; Moriya Tsuji; Dirk M Zajonc; Mitchell Kronenberg
Journal:  Nat Immunol       Date:  2011-09-04       Impact factor: 25.606

10.  In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment.

Authors:  Akio Ohta; Rohan Diwanji; Radhika Kini; Meenakshi Subramanian; Akiko Ohta; Michail Sitkovsky
Journal:  Front Immunol       Date:  2011-07-05       Impact factor: 7.561

View more
  21 in total

Review 1.  Innate T cells in the intensive care unit.

Authors:  Edy Yong Kim; William M Oldham
Journal:  Mol Immunol       Date:  2018-12-13       Impact factor: 4.407

2.  Metabolic Triggers of Invariant Natural Killer T-Cell Activation during Sterile Autoinflammatory Disease.

Authors:  Thomas Riffelmacher; Mitchell Kronenberg
Journal:  Crit Rev Immunol       Date:  2020       Impact factor: 2.214

Review 3.  Unconventional T cells and kidney disease.

Authors:  Hannah Kaminski; Lionel Couzi; Matthias Eberl
Journal:  Nat Rev Nephrol       Date:  2021-08-26       Impact factor: 28.314

4.  Network Pharmacology-Based Exploration of the Therapeutic Mechanisms of Cordyceps cicadae in Renal Ischemia/Reperfusion.

Authors:  Jiajun Dong; Mingyang Cao; Hui Yu; Yang Dong; Conghui Han
Journal:  Ann Transplant       Date:  2022-09-30       Impact factor: 1.479

Review 5.  Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.

Authors:  Sophie Van Welden; Andrew C Selfridge; Pieter Hindryckx
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-30       Impact factor: 46.802

Review 6.  Hypoxia-dependent regulation of inflammatory pathways in immune cells.

Authors:  Cormac T Taylor; Glen Doherty; Padraic G Fallon; Eoin P Cummins
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

Review 7.  Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.

Authors:  S Chouaib; M Z Noman; K Kosmatopoulos; M A Curran
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

Review 8.  Regulation of immunity and inflammation by hypoxia in immunological niches.

Authors:  Cormac T Taylor; Sean P Colgan
Journal:  Nat Rev Immunol       Date:  2017-10-03       Impact factor: 53.106

9.  Activated natural killer T cells in mice induce acute kidney injury with hematuria through possibly common mechanisms shared by human CD56+ T cells.

Authors:  Takahiro Uchida; Hiroyuki Nakashima; Seigo Ito; Takuya Ishikiriyama; Masahiro Nakashima; Shuhji Seki; Hiroo Kumagai; Naoki Oshima
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-11

Review 10.  Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges.

Authors:  Lingling Zhu; Xianzhe Yu; Li Wang; Jiewei Liu; Zihan Qu; Honge Zhang; Lu Li; Jiang Chen; Qinghua Zhou
Journal:  Oncogenesis       Date:  2021-07-10       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.